Home  >  TopNews
Policy & Regulations
+ Font Resize -

CIPMMA urges DCGI to provide prior information to industry about listing of drugs under ‘banned category’

Peethaambaran Kunnathoor, Chennai
Tuesday, June 21, 2016, 08:00 Hrs  [IST]

The Consortium of Indian Pharmaceutical Manufacturers & Marketers Association (CIPMMA) has urged the Drugs Controller General of India (DCGI) to provide prior information to the industry about listing of drugs under ‘banned category’.

“The manufacturers and marketers in the country should be given advance information about listing of drugs under banned category”, a resolution passed in the 9th annual conference of the Trichy-based CIPMMA urged the Union government and DCGI.

As well, in future they should be provided adequate time to liquidate the pharmaceutical products in their stocks or under production before the announcement of the ban comes. In the same way, when a new price is fixed for a drug or when the government wants to withdraw a drug from the market, similar procedure should be adopted, the resolution says.

The annual conference of the marketers association was held at Kovalam near Chennai last week.

A second resolution, which is also meant to be submitted to the Union government and was passed in the AGM, demands for policy draft for ‘separate licence for pharma marketing companies’. Currently, the marketers are operating on wholesale or retail licences.

Highlighting the supportive measures given to the pharma industry by the governments of Telangana and Andhra Pradesh, CIPMMA, seeking categorical support from the government of Tamil Nadu through a resolution wanted the government to identify and allot sufficient land for a comprehensive pharma park for the pharmaceutical industry. CIPMMA wanted the government to supply the industrial units to be set up in the park electricity and water on a subsidized rate. Further, by giving tax benefits the area of the industrial park should be made as ‘excise free zone’.

The annual meeting took another resolution and was passed unanimously by the members. It demands the state government to set up a centralized analytical laboratory for the pharma MSME sector in Tamil Nadu. Similarly, a research and development (R&D) facility under the state government should be established for the pharmaceutical sector of Tamil Nadu. All the members of CIPMMA have unanimously supported the four resolutions.

The newly elected chairman of the Consortium, A. Kannan, said the first two resolutions will be submitted to the Union health minister and to the DCGI after mobilizing support from all the pharma marketers in the country. He said that CIPMMA has brought the long pending demand of the pharma marketers in the form a resolution and will be submitted on behalf of all the marketing people in the country.

The third and fourth resolutions are state issues, so they will be submitted to the state health minister and to the director of drugs control department, he said.

The president of CIPMMA, A. Ramaswani presided over the meeting. Karuani Kadal presented the resolutions. Joseph Martin, secretary of CIPMMA welcomed the audience. More than 250 delegates from all over Tamil Nadu attended the meeting.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
IPJPI_150x60en_2017
CPhI-WWW-150x60-stat-v1
IPJPI_150x60en_2017
IPJPI_150x60en_2017
chemspec2017
chemspec2017
chemspec2017
cphikorea_150x60_k
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |